NCT05486689 is a NA clinical trial of Pulmonary Rehabilitation in Asthma, sponsored by Istituti Clinici Scientifici Maugeri SpA.

Who is sponsoring NCT05486689?

NCT05486689 is sponsored by Istituti Clinici Scientifici Maugeri SpA.

What drugs are being tested in NCT05486689?

Interventions in NCT05486689: Pulmonary Rehabilitation.

What condition does NCT05486689 study?

NCT05486689 studies Asthma, Physical Activity.

Is NCT05486689 still recruiting?

NCT05486689 is currently completed. Last updated 6 December 2023.

Last reviewed 2023-12-06 · How we verify

NCT05486689

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Physical Activity in Asthmatic Subjects

Completed NA Last updated 6 December 2023

What this trial tests

NA trial testing Pulmonary Rehabilitation in Asthma in 17 participants. Completed in 5 December 2023.

Timeline

30 June 2022

Primary endpoint
1 December 2023

5 December 2023

Quick facts

Lead sponsor	Istituti Clinici Scientifici Maugeri SpA
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	17
Start date	30 June 2022
Primary completion	1 December 2023
Estimated completion	5 December 2023
Sites	1 location across Italy

Drugs / interventions tested

Pulmonary Rehabilitation

Conditions studied

Asthma — all drugs for Asthma →
Physical Activity — all drugs for Physical Activity →

Sponsor

Istituti Clinici Scientifici Maugeri SpA

Who can join

Adults 50 to 75, any sex, with Asthma or Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Asthma is a chronic disease, which leads to a number of adverse outcomes, including lower levels of physical activity (PA). Physical inactivity is an important risk factor, increasing PA has become a patient-centred goal for the treatment of subjects with asthma. Data provided by activity monitors are commonly used to measure daily PA. A recent systematic review showed that adults with asthma had lower levels of total, moderate and vigorous physical activity than those without asthma. There are no data showing the possible effects of a Pulmonary Rehabilitation (PR) program on PA (number of daily steps) in normal-weight subjects with asthma. The main objective of this pilot study is to obtain estimates of the mean value of number of daily steps, time spent on activity in hours and of other variables in normal-weight subjects with asthma measured before and after the PR program. No estimates about these parameters in the same population are currently available from literature search.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluation of physical activity before and after respiratory rehabilitation in normal weight individuals with asthma: a feasibility study.
Oliva FM, Tarasconi M, Malovini A, Zappa M, et al · · 2024 · PMID 38783863 · DOI 10.3389/fspor.2024.1372048

Verify or expand the search:

Other trials of Pulmonary Rehabilitation

Trials testing the same drug.

NCT07197229 — Hospital- and Home-Based Structured Pulmonary Rehabilitation in Recently Admitted COPD Patients: A Quasi-Experimental St · NA · not yet recruiting
NCT07376161 — Inflammation and Oxidative Stress in COPD · enrolling by invitation
NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
NCT06756230 — Downhill Walking in IPF · NA · recruiting
NCT06707623 — CPET Guided Rehab vs Physiotherapy in Patients With Dysfunctional Breathing · NA · recruiting

Other recruiting trials for Asthma

Currently open trials in the same condition.

NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting

Other Istituti Clinici Scientifici Maugeri SpA trials

Trials by the same sponsor.

NCT07521436 — Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and Men · not yet recruiting
NCT07451977 — Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia · NA · recruiting
NCT07448181 — Real-life Ecological Momentary Assessment of Lived Burden in Hereditary AngioEdema · recruiting
NCT07432204 — Therapeutic Music Listening in Post Stroke Patients. · NA · recruiting
NCT07399418 — TRIAD - Tracking Risk in Integrated Alzheimer's Diagnostics. · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05486689 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istituti Clinici Scientifici Maugeri SpA
Last refreshed: 6 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05486689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing